MedTrace Logo

Dual Stimulation for Spinal Cord Injury

NCT07467850 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2026-03-12

No results posted yet for this study

Summary

The goal of this Spinal Cord Injury (SCI) Open-Label Clinical Trial is to test the safety and feasibility of the intervention. The study aims to answer whether implementing this intervention on inpatients at a specialized rehabilitation hospital is possible. All participants will receive the intervention and be asked to report side effects and tolerability. Additionally, injury markers for safety and signal recordings to detect changes will be assessed pre- and post-intervention.

Conditions

  • Spinal Cord Injuries

Interventions

DEVICE

tsDCS+pDCS

Pathmaker Neurosystems Inc. "MyoRegulator" trans-spinal and peripheral direct current stimulation.

DEVICE

Low-level laser therapy

Erchonia Corp. "Erchonia FX405" low level laser

Sponsors & Collaborators

  • PathMaker Neurosystems Inc.

    collaborator INDUSTRY

  • Erchonia Corporation

    collaborator INDUSTRY

  • Spaulding Rehabilitation Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-14
Primary Completion
2024-07-01
Completion
2024-09-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07467850 on ClinicalTrials.gov